Weekly Recap: Enhertu first—line HER2—mutant NSCLC and NTK suit dismissed

Daiichi Sankyo Company, Limited (TSE:4568) reported DESTINY-Lung04 showed Enhertu significantly improved PFS (14.3 months; HR 0.63), ORR (70% vs 44.5%) and PFS2, though ILD and grade≥3 AEs were notable, while a Tokyo court dismissed NTK’s damage claim tied to the 2018 Fortis deal.Previous Week Reca…